The executive order would require other countries to pay more for medications so that Americans could pay less. But experts aren’t sure it will work.

Trump's executive order sets a deadline for drugmakers to lower the cost of prescription drugs in the U.S. or face new limits on what the government will pay.

A new phase: Since before he became secretary, Kennedy has talked about using AI in myriad ways, including to provide concierge care to far-flung Americans. But during this hearing, he narrowed in on AI’s potential use to dramatically alter clinical trials.

On May 12, 2025, President Donald Trump signed the executive order (EO) “ Delivering Most-Favored-Nation Prescription Drug Pricing To American Patients .” The EO sets forth policy positions that attempt to further reign in drug prices beyond the scope of drug price negotiation under the Inflation Reduction Act (IRA).

Kennedy Jr., asking if they could speak. The two men knew one another well. In 2023, Mr. Buhler appeared on Mr. Kennedy’s “RFK Jr Podcast,” discussing ... By taking GLP-1s off the drug shortage list, the FDA was pricing out millions of Americans.

“Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%,” Trump posted on Sunday evening. “They will rise throughout the World in order to equalize and, for the first time in many years, bring FAIRNESS TO AMERICA!”

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower prices paid in other countries, what’s called most-favored-nation pricing. If drug companies do not lower their prices accordingly,

From my colleague Jason Mast: The first ever patient has been treated with prime editing, a powerful technology for making precise changes to DNA.